The current valuation score of Savara Inc is 7.70, ranking 204 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.85, which is -60.26% below the recent high of -3.91 and -71.39% above the recent low of -16.88.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.